Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $28.82 - 0.59
January 16, 20184:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q3 2017 Investor Presentation

Annual Reports

Download Documentation 2016 Annual Report to Stockholders

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Systems Technology, Inc. Reports Preliminary Full Year and Fourth Quarter 2017 Revenue Results

January 8, 2018

2017 Revenue Increased 28% to 29% Year-Over-Year; Fourth Quarter Revenue Increased 20% to 21% Year-O... 

Read More >

Tactile Medical to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference

December 7, 2017

MINNEAPOLIS, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”... 

Read More >

Upcoming Events

There are currently no events scheduled.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet